Switch to:
Also traded in: Germany, Mexico

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 0.39
MCK's Cash to Debt is ranked lower than
61% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.57 vs. MCK: 0.39 )
Ranked among companies with meaningful Cash to Debt only.
MCK' s Cash to Debt Range Over the Past 10 Years
Min: 0.05  Med: 0.52 Max: 3.01
Current: 0.39
0.05
3.01
Equity to Asset 0.16
MCK's Equity to Asset is ranked lower than
88% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.40 vs. MCK: 0.16 )
Ranked among companies with meaningful Equity to Asset only.
MCK' s Equity to Asset Range Over the Past 10 Years
Min: 0.15  Med: 0.26 Max: 0.35
Current: 0.16
0.15
0.35
Interest Coverage 10.22
MCK's Interest Coverage is ranked higher than
50% of the 34 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.22 vs. MCK: 10.22 )
Ranked among companies with meaningful Interest Coverage only.
MCK' s Interest Coverage Range Over the Past 10 Years
Min: 7.94  Med: 9.13 Max: 12.77
Current: 10.22
7.94
12.77
F-Score: 5
Z-Score: 4.38
M-Score: -2.43
WACC vs ROIC
7.93%
18.53%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 1.88
MCK's Operating margin (%) is ranked lower than
70% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.96 vs. MCK: 1.88 )
Ranked among companies with meaningful Operating margin (%) only.
MCK' s Operating margin (%) Range Over the Past 10 Years
Min: 1.12  Med: 1.64 Max: 1.9
Current: 1.88
1.12
1.9
Net-margin (%) 1.05
MCK's Net-margin (%) is ranked lower than
70% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.85 vs. MCK: 1.05 )
Ranked among companies with meaningful Net-margin (%) only.
MCK' s Net-margin (%) Range Over the Past 10 Years
Min: 0.77  Med: 0.98 Max: 1.16
Current: 1.05
0.77
1.16
ROE (%) 22.46
MCK's ROE (%) is ranked higher than
88% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.13 vs. MCK: 22.46 )
Ranked among companies with meaningful ROE (%) only.
MCK' s ROE (%) Range Over the Past 10 Years
Min: 13.37  Med: 16.25 Max: 19.97
Current: 22.46
13.37
19.97
ROA (%) 3.55
MCK's ROA (%) is ranked higher than
50% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.55 vs. MCK: 3.55 )
Ranked among companies with meaningful ROA (%) only.
MCK' s ROA (%) Range Over the Past 10 Years
Min: 2.79  Med: 4.01 Max: 4.73
Current: 3.55
2.79
4.73
ROC (Joel Greenblatt) (%) 136.22
MCK's ROC (Joel Greenblatt) (%) is ranked higher than
93% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 23.26 vs. MCK: 136.22 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
MCK' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 56.83  Med: 115.89 Max: 183.42
Current: 136.22
56.83
183.42
Revenue Growth (3Y)(%) 15.90
MCK's Revenue Growth (3Y)(%) is ranked higher than
78% of the 36 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.90 vs. MCK: 15.90 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
MCK' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -7.8  Med: 11.60 Max: 26.5
Current: 15.9
-7.8
26.5
EBITDA Growth (3Y)(%) 16.70
MCK's EBITDA Growth (3Y)(%) is ranked higher than
76% of the 34 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.70 vs. MCK: 16.70 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
MCK' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -52.7  Med: 11.90 Max: 171.6
Current: 16.7
-52.7
171.6
EPS Growth (3Y)(%) 10.50
MCK's EPS Growth (3Y)(%) is ranked higher than
53% of the 32 Companies
in the Global Medical Distribution industry.

( Industry Median: 8.80 vs. MCK: 10.50 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
MCK' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -44.5  Med: 12.30 Max: 87.1
Current: 10.5
-44.5
87.1
» MCK's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2015

MCK Guru Trades in Q1 2015

Paul Tudor Jones 5,179 sh (New)
Joel Greenblatt 1,702 sh (New)
Daniel Loeb 625,600 sh (New)
Ray Dalio 53,313 sh (+138.93%)
Pioneer Investments 467,336 sh (+0.72%)
Vanguard Health Care Fund 6,342,800 sh (unchged)
Ken Fisher Sold Out
Mario Gabelli 17,485 sh (-0.03%)
Scott Black 38,776 sh (-0.18%)
Leon Cooperman 699,203 sh (-2.24%)
Larry Robbins 1,243,960 sh (-8.02%)
Steven Cohen 7,200 sh (-52.00%)
Lee Ainslie 432,691 sh (-66.90%)
» More
Q2 2015

MCK Guru Trades in Q2 2015

Jim Simons 546,400 sh (New)
Andreas Halvorsen 625,568 sh (New)
Joel Greenblatt 229,882 sh (+13406.58%)
Paul Tudor Jones 6,881 sh (+32.86%)
Pioneer Investments 476,784 sh (+2.02%)
Vanguard Health Care Fund 6,342,800 sh (unchged)
Lee Ainslie Sold Out
Steven Cohen Sold Out
Daniel Loeb Sold Out
Mario Gabelli 17,300 sh (-1.06%)
Scott Black 38,358 sh (-1.08%)
Leon Cooperman 691,603 sh (-1.09%)
Larry Robbins 1,025,749 sh (-17.54%)
Ray Dalio 29,713 sh (-44.27%)
» More
Q3 2015

MCK Guru Trades in Q3 2015

Ken Fisher 6,433 sh (New)
Steven Cohen 4,700 sh (New)
First Pacific Advisors 47,405 sh (New)
Andreas Halvorsen 2,274,228 sh (+263.55%)
Larry Robbins 1,810,249 sh (+76.48%)
Joel Greenblatt 280,458 sh (+22.00%)
Paul Tudor Jones 8,278 sh (+20.30%)
Mario Gabelli 17,700 sh (+2.31%)
Vanguard Health Care Fund 6,471,080 sh (+2.02%)
Pioneer Investments 485,930 sh (+1.92%)
Leon Cooperman Sold Out
Scott Black 38,293 sh (-0.17%)
Jim Simons 535,500 sh (-1.99%)
Ray Dalio 26,713 sh (-10.10%)
» More
Q4 2015

MCK Guru Trades in Q4 2015

Vanguard Health Care Fund 6,619,780 sh (+2.30%)
Ken Fisher Sold Out
Mario Gabelli 13,925 sh (-21.33%)
» More
» Details

Insider Trades

Latest Guru Trades with MCK

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about McKesson Corp

McKesson Officer Sells 101,835 Shares of Company Company announced in September plans to acquire pharmaceutical distribution division of UDG Healthcare
McKesson Corp. (MCK) CEO, President and Chairman John Hammergren (Insider Trades) sold 101,835 shares of the company on Oct. 12. The average price per share was $190.51. McKesson is a healthcare service and information technology company dedicated to making the business of healthcare run well. The company has a market cap of $44.11 billion and a P/S ratio of 0.24. Read more...
Weekly Insider Sells Highlight: MCK, FEYE, GOOG, CI
According to GuruFocus Insider Data, the largest insider sells during the past week were: McKesson Corp, FireEye Inc, Google Inc, and Cigna Corp. Read more...
Leon Cooperman's Top Growth Stocks
Leon Cooperman (Trades, Portfolio)'s firm Omega Advisors is one of the largest hedge funds that has maintained a quarter over quarter turnover around 17%. Even in 2008 during the financial crisis, Cooperman was able to beat the market by staying away from the financial stocks. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 17.93
MCK's P/E(ttm) is ranked higher than
69% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 21.00 vs. MCK: 17.93 )
Ranked among companies with meaningful P/E(ttm) only.
MCK' s P/E(ttm) Range Over the Past 10 Years
Min: 8.15  Med: 18.49 Max: 38.36
Current: 17.93
8.15
38.36
Forward P/E 10.89
MCK's Forward P/E is ranked higher than
87% of the 31 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.74 vs. MCK: 10.89 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 15.71
MCK's PE(NRI) is ranked higher than
77% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 22.35 vs. MCK: 15.71 )
Ranked among companies with meaningful PE(NRI) only.
MCK' s PE(NRI) Range Over the Past 10 Years
Min: 8.17  Med: 18.34 Max: 33.78
Current: 15.71
8.17
33.78
P/B 3.89
MCK's P/B is ranked lower than
87% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.10 vs. MCK: 3.89 )
Ranked among companies with meaningful P/B only.
MCK' s P/B Range Over the Past 10 Years
Min: 1.31  Med: 2.70 Max: 6.98
Current: 3.89
1.31
6.98
P/S 0.19
MCK's P/S is ranked higher than
88% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.62 vs. MCK: 0.19 )
Ranked among companies with meaningful P/S only.
MCK' s P/S Range Over the Past 10 Years
Min: 0.08  Med: 0.18 Max: 0.32
Current: 0.19
0.08
0.32
PFCF 18.84
MCK's PFCF is ranked higher than
50% of the 34 Companies
in the Global Medical Distribution industry.

( Industry Median: 18.96 vs. MCK: 18.84 )
Ranked among companies with meaningful PFCF only.
MCK' s PFCF Range Over the Past 10 Years
Min: 4.69  Med: 12.15 Max: 41.74
Current: 18.84
4.69
41.74
POCF 14.50
MCK's POCF is ranked higher than
58% of the 45 Companies
in the Global Medical Distribution industry.

( Industry Median: 15.00 vs. MCK: 14.50 )
Ranked among companies with meaningful POCF only.
MCK' s POCF Range Over the Past 10 Years
Min: 4.25  Med: 10.22 Max: 88.45
Current: 14.5
4.25
88.45
EV-to-EBIT 11.18
MCK's EV-to-EBIT is ranked higher than
67% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 14.58 vs. MCK: 11.18 )
Ranked among companies with meaningful EV-to-EBIT only.
MCK' s EV-to-EBIT Range Over the Past 10 Years
Min: -864.9  Med: 11.10 Max: 22.1
Current: 11.18
-864.9
22.1
EV-to-EBITDA 8.92
MCK's EV-to-EBITDA is ranked higher than
87% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.75 vs. MCK: 8.92 )
Ranked among companies with meaningful EV-to-EBITDA only.
MCK' s EV-to-EBITDA Range Over the Past 10 Years
Min: 4.5  Med: 9.30 Max: 117.2
Current: 8.92
4.5
117.2
PEG 1.02
MCK's PEG is ranked higher than
74% of the 23 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.94 vs. MCK: 1.02 )
Ranked among companies with meaningful PEG only.
MCK' s PEG Range Over the Past 10 Years
Min: 0.15  Med: 1.25 Max: 9.61
Current: 1.02
0.15
9.61
Shiller P/E 28.82
MCK's Shiller P/E is ranked lower than
56% of the 25 Companies
in the Global Medical Distribution industry.

( Industry Median: 26.83 vs. MCK: 28.82 )
Ranked among companies with meaningful Shiller P/E only.
MCK' s Shiller P/E Range Over the Past 10 Years
Min: 14.91  Med: 30.28 Max: 51.63
Current: 28.82
14.91
51.63
Current Ratio 1.11
MCK's Current Ratio is ranked lower than
86% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.49 vs. MCK: 1.11 )
Ranked among companies with meaningful Current Ratio only.
MCK' s Current Ratio Range Over the Past 10 Years
Min: 1.08  Med: 1.27 Max: 1.71
Current: 1.11
1.08
1.71
Quick Ratio 0.63
MCK's Quick Ratio is ranked lower than
91% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.04 vs. MCK: 0.63 )
Ranked among companies with meaningful Quick Ratio only.
MCK' s Quick Ratio Range Over the Past 10 Years
Min: 0.52  Med: 0.65 Max: 0.88
Current: 0.63
0.52
0.88
Days Inventory 31.75
MCK's Days Inventory is ranked higher than
75% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 52.54 vs. MCK: 31.75 )
Ranked among companies with meaningful Days Inventory only.
MCK' s Days Inventory Range Over the Past 10 Years
Min: 29.7  Med: 31.95 Max: 32.98
Current: 31.75
29.7
32.98
Days Sales Outstanding 33.89
MCK's Days Sales Outstanding is ranked higher than
80% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 56.51 vs. MCK: 33.89 )
Ranked among companies with meaningful Days Sales Outstanding only.
MCK' s Days Sales Outstanding Range Over the Past 10 Years
Min: 22.03  Med: 26.10 Max: 32.33
Current: 33.89
22.03
32.33
Days Payable 55.65
MCK's Days Payable is ranked lower than
71% of the 41 Companies
in the Global Medical Distribution industry.

( Industry Median: 74.19 vs. MCK: 55.65 )
Ranked among companies with meaningful Days Payable only.
MCK' s Days Payable Range Over the Past 10 Years
Min: 44.11  Med: 50.63 Max: 59.76
Current: 55.65
44.11
59.76

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.68
MCK's Dividend Yield is ranked lower than
92% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.96 vs. MCK: 0.68 )
Ranked among companies with meaningful Dividend Yield only.
MCK' s Dividend Yield Range Over the Past 10 Years
Min: 0.35  Med: 0.60 Max: 1.42
Current: 0.68
0.35
1.42
Dividend Payout 0.11
MCK's Dividend Payout is ranked higher than
97% of the 36 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.34 vs. MCK: 0.11 )
Ranked among companies with meaningful Dividend Payout only.
MCK' s Dividend Payout Range Over the Past 10 Years
Min: 0.04  Med: 0.13 Max: 6
Current: 0.11
0.04
6
Dividend Growth (3y) 6.30
MCK's Dividend Growth (3y) is ranked lower than
81% of the 21 Companies
in the Global Medical Distribution industry.

( Industry Median: 16.60 vs. MCK: 6.30 )
Ranked among companies with meaningful Dividend Growth (3y) only.
MCK' s Dividend Growth (3y) Range Over the Past 10 Years
Min: -21.7  Med: 0.00 Max: 44.2
Current: 6.3
-21.7
44.2
Forward Dividend Yield 0.74
MCK's Forward Dividend Yield is ranked lower than
90% of the 50 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.02 vs. MCK: 0.74 )
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield on cost (5-Year) 1.24
MCK's Yield on cost (5-Year) is ranked lower than
87% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.95 vs. MCK: 1.24 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
MCK' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0.64  Med: 1.10 Max: 2.59
Current: 1.24
0.64
2.59
3-Year Average Share Buyback Ratio 2.20
MCK's 3-Year Average Share Buyback Ratio is ranked higher than
87% of the 32 Companies
in the Global Medical Distribution industry.

( Industry Median: -1.00 vs. MCK: 2.20 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
MCK' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -43.4  Med: -0.50 Max: 4.3
Current: 2.2
-43.4
4.3

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 0.89
MCK's Price/Projected FCF is ranked higher than
75% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.20 vs. MCK: 0.89 )
Ranked among companies with meaningful Price/Projected FCF only.
MCK' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.55  Med: 1.04 Max: 17.04
Current: 0.89
0.55
17.04
Price/DCF (Earnings Based) 2.00
MCK's Price/DCF (Earnings Based) is ranked lower than
71% of the 14 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.49 vs. MCK: 2.00 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.04
MCK's Price/Median PS Value is ranked higher than
54% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.95 vs. MCK: 1.04 )
Ranked among companies with meaningful Price/Median PS Value only.
MCK' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.01  Med: 1.02 Max: 4.22
Current: 1.04
0.01
4.22
Price/Peter Lynch Fair Value 0.90
MCK's Price/Peter Lynch Fair Value is ranked higher than
76% of the 25 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.28 vs. MCK: 0.90 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
MCK' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.34  Med: 1.21 Max: 72.67
Current: 0.9
0.34
72.67
Earnings Yield (Greenblatt) (%) 8.99
MCK's Earnings Yield (Greenblatt) (%) is ranked higher than
73% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.10 vs. MCK: 8.99 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
MCK' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 4.5  Med: 8.80 Max: 17.6
Current: 8.99
4.5
17.6
Forward Rate of Return (Yacktman) (%) 23.49
MCK's Forward Rate of Return (Yacktman) (%) is ranked higher than
79% of the 29 Companies
in the Global Medical Distribution industry.

( Industry Median: 13.68 vs. MCK: 23.49 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
MCK' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -34  Med: 20.20 Max: 94.5
Current: 23.49
-34
94.5

More Statistics

Revenue(Mil) $187430
EPS $ 8.37
Beta1.01
Short Percentage of Float1.31%
52-Week Range $148.66 - 243.61
Shares Outstanding(Mil)228.59

Analyst Estimate

Mar16 Mar17 Mar18
Revenue(Mil) 190,571 199,352 203,013
EPS($) 12.42 13.90 15.00
EPS without NRI($) 12.42 13.90 15.00

Latest Earnings Webcast

» More Conference Calls

Business Description

Industry: Medical Distribution » Medical Distribution
Compare:ABC, CAH, SHTDF, HSIC, PDCO » details
Traded in other countries:MCK.Germany, MCK.Mexico,
McKesson Corporation is a Delaware Corporation. The Company delivers pharmaceuticals, medical supplies and healthcare information technology that make healthcare safer while reducing costs. The Company operates in two segments. The McKesson Distribution Solutions segment distributes ethical and proprietary drugs and equipment and health and beauty care products throughout North America and internationally. This segment provides specialty pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. This segment also provides medical-surgical supply distribution, equipment, logistics and other services to healthcare providers through a network of distribution centers within the U.S. In addition, this segment sells financial, operational and clinical solutions for pharmacies (retail, hospital, alternate site) and provides consulting, outsourcing and other services. The McKesson Technology Solutions segment includes McKesson Health Solutions, which includes its InterQual clinical criteria solution, claims payment solutions and network performance tools. This segment also delivers enterprise-wide clinical, patient care, financial, supply chain, strategic management software solutions, as well as connectivity, outsourcing and other services, including remote hosting and managed services, to healthcare organizations. This segment's customers include hospitals, physicians, homecare providers, retail pharmacies and payers from North America. McKesson Distribution Solutions consists of the following businesses: North America pharmaceutical distribution and services, International pharmaceutical distribution and services and Medical Surgical distribution and services. The Company competes with other software services firms, consulting firms, shared service vendors, certain hospitals and hospital groups, payers, care management organizations, hardware vendors and internet-based companies with technology applicable to the healthcare industry.
» More Articles for MCK

Headlines

Articles On GuruFocus.com
A Short-Term Problem Creates Long-Term Opportunity in Lannett Company Jan 12 2016 
Larry Robbins Buys Cigna, Monsanto and Sells Out McDonald's Dec 09 2015 
A Look at Recent Insider Trades Oct 16 2015 
McKesson Officer Sells 101,835 Shares of Company Oct 15 2015 
The Case for Investing in AmerisourceBergen Aug 13 2015 
Weekly Insider Sells Highlight: MCK, FEYE, GOOG, CI Jul 21 2015 
Litespeed Management adds to its stake in MedAssets Jul 07 2015 
Why Hedge Funds Are Betting On AmerisourceBergen Apr 10 2015 
Rite Aid – What To Expect From Q4 And Full Fiscal Earnings Report Tomorrow Apr 07 2015 
Larry Robbins' Top Growth Stocks Mar 25 2015 

More From Other Websites
McKesson to Open Call Center in Port St. Lucie Feb 09 2016
Credit Suisse Picks 7 Health Care Stocks to Own for the Next 6 Months Feb 06 2016
Fundamental Factors Moving Markets -- Analyst Notes on Morgan Stanley, Anadarko Petroleum,... Feb 04 2016
Black Lives Matter activist DeRay Mckesson is running for mayor of Baltimore Feb 03 2016
A major figure in the Black Lives Matter movement is running for mayor of Baltimore Feb 03 2016
Cramer Remix: Don’t be stupid—buy this stock Feb 03 2016
Why Are Influential Insiders Selling Shares of These Companies? Feb 03 2016
The C-Suite Speaks: Business as Usual? Feb 02 2016
MCKESSON CORP Financials Feb 02 2016
McKesson Corp. Earnings Analysis: Q3, 2016 By the Numbers Feb 02 2016
Indiana Radiology Group Contracts with McKesson Feb 02 2016
MCKESSON CORP Files SEC form 8-K, Material Impairments Feb 01 2016
McKesson Releases FY2015 Corporate Citizenship Report Jan 29 2016
Heres what CEOs said on this week’s earnings calls Jan 29 2016
Rachel Sharp Joins McKesson Health Solutions as Managing Director for InterQual in U.K. and Ireland Jan 28 2016
Livanta Selects InterQual to Support its Medicare Utilization and Quality Care Reviews Jan 28 2016
Rite-Aid 2015 Comps Rise As Acquisition Looms Jan 28 2016
McKesson Q3 Earnings Top on Low Tax Rate, Revenues Miss Jan 28 2016
Edited Transcript of MCK earnings conference call or presentation 27-Jan-16 10:00pm GMT Jan 28 2016
[$$] McKesson Profit Rises on Lower Tax Rate Jan 27 2016
McKesson Declares Quarterly Dividend January 2016 Jan 27 2016
McKesson Reports Fiscal 2016 Third Quarter Results Jan 27 2016
McKesson Declares Quarterly Dividend January 27, 2016 Jan 27 2016
MCKESSON CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jan 27 2016
McKesson Reports Fiscal 2016 Third-Quarter Results Jan 27 2016
Q3 2016 McKesson Corp Earnings Release - 4:00 pm ET Jan 27 2016
McKesson Launches Clinical Programs Solution Jan 25 2016
The Military Health System Selects InterQual for Utilization Management Jan 21 2016
McKesson Corporation to Present at the Leerink Partners 5th Annual Global Healthcare Conference Jan 20 2016
New McKesson ClaimsXten Solutions Help Payers of all Sizes Streamline, Automate, and Scale... Jan 19 2016
EU mergers and takeovers (Jan 15) Jan 15 2016
McKesson Provider Sites Committed to CommonWell Services Jan 14 2016
McKesson Specialty Health’s Reimbursement, Access & Safety Services Solution Center Named Center... Jan 14 2016
Chinese stocks fluctuate, fueling Asian market volatility Jan 11 2016
McKesson Announces Fiscal 2016 Earnings Update and Preliminary Fiscal 2017 Outlook Jan 11 2016
West Virginia attorney general sues drug wholesaler Jan 08 2016
McKesson Corporation Fiscal 2016 Third Quarter Conference Call Scheduled for January 27, 2016 Jan 05 2016
McKesson Recommends Shareholders Reject "Mini-Tender" Offer by TRC Capital Corporation Dec 23 2015
McKesson Corporation to Present at 34th Annual J.P. Morgan Healthcare Conference Dec 22 2015
McKesson Honored as a ‘Best Place to Work’ for Third Year in a Row by Human Rights Campaign... Dec 14 2015
McKesson Specialty Health Hosts 2015 Onmark Select Program Fall Leadership Summit For... Dec 09 2015
eQHealth Solutions Chooses McKesson’s InterQual for Clinical Decision Support Dec 07 2015
McKesson Pharmacy Optimization® Team Identifies Five Health System Pharmacy Trends to Watch in 2016 Dec 07 2015
McKesson to Spotlight Solutions at ASHP Midyear Clinical Meeting 2015 Dec 04 2015
McKesson tops Street 2Q forecasts Oct 29 2015
IT Spending in Remote Healthcare Delivery Market – Trends, Forecast & Growth Prospects Unveiled by... Oct 02 2015
UDG Healthcare sells off £300m drugs business Sep 18 2015
BUZZ-UDG Healthcare: jumps on asset sale Sep 18 2015
Rite Aid beats Street 2Q forecasts Sep 17 2015
McKesson beats Street 1Q forecasts Jul 29 2015
McKesson Reports Fiscal 2016 First-Quarter Results Jul 29 2015
Celesio buys Sainsbury's pharmacies Jul 29 2015
McKesson beats Street 4Q forecasts May 12 2015
Workforce Management (WFM) Software Market in Healthcare – Global Market Survey, Forecast & Growth... May 12 2015
McKesson Corp. revealed as the Clear Lake mystery company Feb 19 2015
McKesson tops Street 3Q forecasts Feb 05 2015
McKesson tops Street 2Q forecasts Oct 28 2014
US pharma giant buys Germany's Celesio in $8-bn deal Oct 24 2013

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK